Microsoft has highlighted the "remarkable" adoption of SQL Server 2025 on Linux, along with some new features.

Microsoft has announced general availability of SQL Server 2025, Fabric Databases, and Rebranded Azure DocumentDB at the ...

Recently approved by the European Medicines Agency, RESTORE will evaluate iadademstat’s ability to raise fetal hemoglobin (HbF) in adult patients with SCD Iadademstat has demonstrated a favorable ...

European Heart Journal publishes SCD-PROTECT study, addressing evidence gap in early SCD risk in the context of four-pillar GDMT for both NICM and MI/CAD patients ZOLL®, an Asahi Kasei company that ...

81.7% of patients were on an SGLT2 inhibitor 74.7% of patients were on an ARNI 95.1% of patients were on a beta-blocker 83.1% of patients were on an MRA Despite high use of GDMT, the rate of ...

Pfizer’s sickle cell disease (SCD) drug has flunked a key phase 3 test, the latest blow to the pharma’s $5.4 billion acquisition of Global Blood Therapeutics. Pfizer acquired the P-selectin inhibitor, ...

The Zuckerberg College of Health Sciences, Department of Public Health, invites you to attend a doctoral dissertation defense by Kaylea Flangan, MPH, RD on “Ultra-Processed Food Consumption, Cognitive ...

SCD seeks total returns with a primary focus on income, investing globally in companies with strong fundamentals and clear market advantages. The fund uses leverage to enhance returns, with interest ...

Clifton Kirkman II moves through life with an invisible weight on his shoulders — and in his blood. A Detroit-based father, journalist, and patient advocate, Clifton has lived with sickle cell disease ...